Your browser doesn't support javascript.
loading
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma.
Märkl, Florian; Benmebarek, Mohamed-Reda; Keyl, Julius; Cadilha, Bruno L; Geiger, Martina; Karches, Clara; Obeck, Hannah; Schwerdtfeger, Melanie; Michaelides, Stefanos; Briukhovetska, Daria; Stock, Sophia; Jobst, Jakob; Müller, Philipp Jie; Majed, Lina; Seifert, Matthias; Klüver, Anna-Kristina; Lorenzini, Theo; Grünmeier, Ruth; Thomas, Moritz; Gottschlich, Adrian; Klaus, Richard; Marr, Carsten; von Bergwelt-Baildon, Michael; Rothenfusser, Simon; Levesque, Mitchell P; Heppt, Markus Vincent; Endres, Stefan; Klein, Christian; Kobold, Sebastian.
  • Märkl F; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Benmebarek MR; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Keyl J; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Cadilha BL; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Geiger M; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland.
  • Karches C; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Obeck H; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Schwerdtfeger M; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Michaelides S; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Briukhovetska D; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Stock S; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Jobst J; Department of Medicine III, Klinikum der Universität München, Munich, Germany.
  • Müller PJ; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Majed L; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Seifert M; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Klüver AK; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Lorenzini T; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Grünmeier R; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Thomas M; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Gottschlich A; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Klaus R; Institute of AI for Health, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Marr C; Institute of Computational Biology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • von Bergwelt-Baildon M; School of Life Sciences Weihenstephan, Technical University of Munich, Munich, Freising, Germany.
  • Rothenfusser S; Department of Medicine IV, Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Levesque MP; Division of Pediatric Nephrology, Department of Pediatrics, Dr. v. Haunersches Kinderspital, Klinikum der Universität München, Munich, Germany.
  • Heppt MV; Institute of AI for Health, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Endres S; Institute of Computational Biology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Klein C; Department of Medicine III, Klinikum der Universität München, Munich, Germany.
  • Kobold S; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
J Immunother Cancer ; 11(5)2023 05.
Article en En | MEDLINE | ID: mdl-37208128
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Melanoma Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Melanoma Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article